AR028281A1 - Derivados de 2-(arilalquilamino) pirimidona y derivados de 2-(heteroaroarilalquilamino) pirimidona - Google Patents
Derivados de 2-(arilalquilamino) pirimidona y derivados de 2-(heteroaroarilalquilamino) pirimidonaInfo
- Publication number
- AR028281A1 AR028281A1 ARP010101373A ARP010101373A AR028281A1 AR 028281 A1 AR028281 A1 AR 028281A1 AR P010101373 A ARP010101373 A AR P010101373A AR P010101373 A ARP010101373 A AR P010101373A AR 028281 A1 AR028281 A1 AR 028281A1
- Authority
- AR
- Argentina
- Prior art keywords
- pirimidona
- derivatives
- heteroaroarilalquilamino
- arilalquilamino
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Neurosurgery (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP00400805A EP1136099A1 (en) | 2000-03-23 | 2000-03-23 | 2-(Indolylalkylamino)pyrimidone derivatives as GSK3beta inhibitors |
JP2000081938A JP2001270884A (ja) | 2000-03-23 | 2000-03-23 | ピリミドン誘導体 |
EP00400806A EP1136491A1 (en) | 2000-03-23 | 2000-03-23 | 2-[(Heteroaryl)alkylamino]pyrimidone derivatives |
EP00400804A EP1136484A1 (en) | 2000-03-23 | 2000-03-23 | 2-(Arylalkylamino)pyrimidone derivatives |
Publications (1)
Publication Number | Publication Date |
---|---|
AR028281A1 true AR028281A1 (es) | 2003-04-30 |
Family
ID=27440051
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP010101373A AR028281A1 (es) | 2000-03-23 | 2001-03-23 | Derivados de 2-(arilalquilamino) pirimidona y derivados de 2-(heteroaroarilalquilamino) pirimidona |
Country Status (3)
Country | Link |
---|---|
AR (1) | AR028281A1 (es) |
AU (1) | AU2001248365A1 (es) |
WO (1) | WO2001070727A1 (es) |
Families Citing this family (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE284712T1 (de) | 2000-04-26 | 2005-01-15 | Eisai Co Ltd | Medizinische zusammensetzungen zur förderung der aktivierung der eingeweide |
TWI335221B (en) * | 2001-09-27 | 2011-01-01 | Alcon Inc | Inhibtors of glycogen synthase kinase-3 (gsk-3) for treating glaucoma |
TWI301834B (en) * | 2001-10-22 | 2008-10-11 | Eisai R&D Man Co Ltd | Pyrimidone compound and pharmaceutical composition including the same |
TWI330183B (es) | 2001-10-22 | 2010-09-11 | Eisai R&D Man Co Ltd | |
US20050203059A1 (en) * | 2002-03-01 | 2005-09-15 | Harrison Stephen D. | Methods and compositions for treatment of ischemia |
EP2221054A1 (en) | 2002-04-30 | 2010-08-25 | Alcon, Inc. | CDK inhibitors for lowering intraocular pressure |
EP1616568A3 (en) * | 2002-04-30 | 2006-06-21 | Alcon, Inc | GSK-3 inhibitors and CDK inhibitors as anti-glaucoma agents |
JP2006506383A (ja) | 2002-10-21 | 2006-02-23 | カイロン コーポレイション | グリコーゲンシンターゼキナーゼ3のインヒビター |
WO2005076854A2 (en) * | 2004-02-04 | 2005-08-25 | Smithkline Beecham Corporation | Pyrimidinone compounds useful as kinase inhibitors |
MX2007008326A (es) | 2005-01-07 | 2008-01-16 | Univ Emory | Antagonistas de cxcr4 para el tratamiento de una infeccion por vih. |
EP2258359A3 (en) | 2005-08-26 | 2011-04-06 | Braincells, Inc. | Neurogenesis by muscarinic receptor modulation with sabcomelin |
JP2009506069A (ja) | 2005-08-26 | 2009-02-12 | ブレインセルス,インコーポレイティド | ムスカリン性受容体調節による神経発生 |
AU2006304787A1 (en) | 2005-10-21 | 2007-04-26 | Braincells, Inc. | Modulation of neurogenesis by PDE inhibition |
CA2625210A1 (en) | 2005-10-31 | 2007-05-10 | Braincells, Inc. | Gaba receptor mediated modulation of neurogenesis |
US20100216734A1 (en) | 2006-03-08 | 2010-08-26 | Braincells, Inc. | Modulation of neurogenesis by nootropic agents |
AU2007249399A1 (en) | 2006-05-09 | 2007-11-22 | Braincells, Inc. | Neurogenesis by modulating angiotensin |
WO2008008854A2 (en) | 2006-07-11 | 2008-01-17 | Emory University | Cxcr4 antagonists including diazine and triazine structures for the treatment of medical disorders |
AU2007275686B2 (en) * | 2006-07-18 | 2013-10-31 | University Of Rochester | Thiadiazolidinone derivatives |
EP2057141B1 (en) * | 2006-08-23 | 2011-10-26 | Pfizer Products Inc. | Pyrimidone compounds as gsk-3 inhibitors |
US20100184806A1 (en) | 2006-09-19 | 2010-07-22 | Braincells, Inc. | Modulation of neurogenesis by ppar agents |
CA2704199C (en) * | 2007-11-01 | 2016-01-19 | Acucela Inc. | Amine derivative compounds for treating ophthalmic diseases and disorders |
WO2010099217A1 (en) | 2009-02-25 | 2010-09-02 | Braincells, Inc. | Modulation of neurogenesis using d-cycloserine combinations |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TW520362B (en) * | 1996-12-05 | 2003-02-11 | Amgen Inc | Substituted pyrimidine compounds and pharmaceutical composition comprising same |
-
2001
- 2001-03-22 WO PCT/EP2001/003638 patent/WO2001070727A1/en not_active Application Discontinuation
- 2001-03-22 AU AU2001248365A patent/AU2001248365A1/en not_active Abandoned
- 2001-03-23 AR ARP010101373A patent/AR028281A1/es unknown
Also Published As
Publication number | Publication date |
---|---|
WO2001070727A1 (en) | 2001-09-27 |
AU2001248365A1 (en) | 2001-10-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR028281A1 (es) | Derivados de 2-(arilalquilamino) pirimidona y derivados de 2-(heteroaroarilalquilamino) pirimidona | |
AR028567A1 (es) | Nuevos derivados de fenil-propargileter | |
AR028596A1 (es) | Nuevos derivados de fenilglicina | |
NO20025978L (no) | Benzotiazol-derivater | |
ID30590A (id) | Celana sekali pakai jenis-celana pendek | |
AR028343A1 (es) | Derivados de pirrolidina y piperidina | |
MA27126A1 (fr) | 3'PROMEDICAMENTS DE 2'-DESOXY- β-L-NUCLEOSIDES | |
AR027938A1 (es) | Compuestos uracilo y utilizacion de los mismos | |
DE60134338D1 (de) | Piperazin-derivate | |
DK1292604T3 (da) | 2-Aminocarbonyl-9H-purinderivater | |
DE60043343D1 (de) | Chromenderivate | |
DE50112013D1 (de) | Deodorantien und antiperspirantien | |
ID30187A (id) | Dongkrak jenis pantagraf | |
ATE298332T1 (de) | Decahydro-isochinolinderivate | |
DK1280809T3 (da) | Antitumorecteinascidinderivater | |
AR028602A1 (es) | Derivados de pirrol | |
PT1246817E (pt) | Derivados de 4-fenil-1-piperazinilo, -piperidinilo e -tetra-hidropiridilo | |
PT1322592E (pt) | Derivados substituidos de 1-aminobutan-3-ol | |
DE60032898D1 (de) | Arylthiazolidindion- und aryloxazolidinderivate | |
AR028607A1 (es) | Derivados de 1,4-diazepan-2,5-diona | |
DE60117096D1 (de) | Dihydroindol- und tetrahydrochinolinderivate | |
DK1246791T3 (da) | Aminomethyl-phenyl-cyklohexanonderivater | |
PT1178984E (pt) | Derivados de 1-trifluorometil-4-hidroxi-7-piperidinilamimometilcromano | |
PT1392670E (pt) | Derivados substituidos de c-furan-2-il-metilamina e c-tiofen-2-il-metilamina | |
AR027964A1 (es) | Combinacion de fibras y derivados epnxicos termoplasticos |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FB | Suspension of granting procedure |